Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment

Front Pharmacol. 2023 May 16:14:1210002. doi: 10.3389/fphar.2023.1210002. eCollection 2023.
No abstract available

Keywords: cost-effectiveness; disinvestment choices; health technology assessment (HTA); patient related outcome; pharmacoeconomics.

Publication types

  • Editorial